p(thyme oil) and p(clove oil) organo‐particles with biocompatible, anticancer, antioxidant, and antibacterial properties against Capan‐1 and L‐929 cells

Abstract

The synthesis of p(ClO) and p(TO) organo‐particles from clove oil and thyme oil is the first in the literature. The particles were tested against the L‐929 cell line for cell viability/cytotoxicity. The anticancer activity was studied against the Capan‐1 pancreatic cancer cell line. p(ClO) and p(TO) organo‐particles were featured by thermogravimetry (TGA), Fourier transform infrared spectroscopy (FT‐IR), scanning electron microscopy (SEM), particle size (DLS), and particle charge (zeta potential, Zeta) analyses. Antioxidant, biocompatible, antimicrobial, and in vitro cytotoxicity specialties were investigated. p(ClO) and p(TO) organo‐particles were found to be effective on the L‐929 fibroblast cell line and Capan‐1 pancreatic cancer cell line in research on Capan‐1 and L‐929 cell lines. Additionally, it was shown that large dosages of p(ClO) organo‐particles were not hazardous to L‐929 cell lines. A difference was found between the rates of cell viability and apoptosis and necrosis when the MTT study findings of p(ClO) and p(TO) organo‐particles were studied in Capan‐1 cell line. The p(TO) organo‐particle had the highest % apoptosis rate. At the 100 g mL−1 concentration, the fibroblast cell viability of p(ClO) and p(TO) organo‐particles was 176.46% and 107.78%, respectively. The IC50 value derived for the decrease in viability was determined as (2.22 mg mL−1) and it was calculated that it would kill the pancreatic cancer cells by 50% when doxorubicin and p(ClO) were administered combined.